CORT

#1379
Corcept Therapeutics Inc.
43.9500 USD
+0.62%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
43.8050
44.0400
Rango anual
28.6601
89.0000
Cambio diario
+0.62%
Variación mensual
+35.82%
Variación en los últimos 6 meses
-40.10%
Cambio anual
-40.10%
Cierres anteriores
43.6800
Abrir
43.8050
Bid
Ask
Mínimo
43.8050
High
44.0400
Volumen
49
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Corcept Therapeutics Incorporated

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Noticias